English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron

MPS-Authors
/persons/resource/persons250710

Contreras,  Sebastian
Max Planck Research Group Neural Systems Theory, Max Planck Institute for Dynamics and Self-Organization, Max Planck Society;

/persons/resource/persons173619

Priesemann,  Viola
Max Planck Research Group Neural Systems Theory, Max Planck Institute for Dynamics and Self-Organization, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Oróstica, K. Y., Contreras, S., Sanchez-Daza, A., Fernandez, J., Priesemann, V., & Olivera-Nappa, Á. (2022). New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron. The Lancet Regional Health - Americas, 7: 100203. doi:10.1016/j.lana.2022.100203.


Cite as: https://hdl.handle.net/21.11116/0000-000C-47C0-B
Abstract
The emergence of SARS-CoV-2 variants with enhanced transmissibility and partial immune escape (also known as Variants of Concern, VOC) has characterised the second year of the COVID-19 pandemic. Genomic surveillance allows identifying hidden, fast-spreading lineages and VOCs before they become a public health threat. The Chilean Public Health Institute (Instituto de Salud Pública, ISP) has led SARS-CoV-2 genomic surveillance initiatives in Chile. Using sequencing data, the ISP has signalled the introduction of VOCs and characterised their transmissibility and mutational signatures, contributing to a better understanding of the local features of the pandemic.